UC San Diego Cancer Scientists Identify New Drug Target for Multiple Tumor Types
A dysfunctional enzyme involved in building cancer cell membranes helps fuel tumor growth; when it’s disabled or depleted in mouse models, tumors shrank significantly.
A dysfunctional enzyme involved in building cancer cell membranes helps fuel tumor growth; when it’s disabled or depleted in mouse models, tumors shrank significantly.
UC San Diego will launch a payload of stem cell-derived human brain organoids to the International Space Station. Researchers will document how these “mini brains” organize into the beginnings of a functional brain with implications for the future of human life in space.
On July 1, 2019, USC and UC San Diego reached a settlement in the ongoing Alzheimer’s disease research lawsuit, Regents of the University of California v. Aisen et al.
Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to machine learning research by researchers at UC San Diego's San Diego Supercomputer Center and Moores Cancer Center.
Adolescent depression increases with exposure to pesticides, a study in the Ecuadorian Andes shows.
UC San Diego School of Medicine researchers identified chemical compounds that prevent stress-induced clumping of TDP-43 protein in ALS motor neurons grown in the lab — a starting point for new ALS therapeutics.
U.S. News & World Report, June 16
U.S. News & World Report, June 9
Women's Health, June 3
The New York Times, June 2
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.